<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F4FA74B3-7DF5-44E3-A340-2B12E0931569"><gtr:id>F4FA74B3-7DF5-44E3-A340-2B12E0931569</gtr:id><gtr:name>Tampere University of Technology</gtr:name><gtr:address><gtr:line1>PO Box 527</gtr:line1><gtr:line4>Tampere</gtr:line4><gtr:postCode>FIN 33101</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Finland</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/926FCE3B-DFAB-4FE7-9BF8-7372B5AA9514"><gtr:id>926FCE3B-DFAB-4FE7-9BF8-7372B5AA9514</gtr:id><gtr:name>German Cancer Research Center</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Medicine</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F4FA74B3-7DF5-44E3-A340-2B12E0931569"><gtr:id>F4FA74B3-7DF5-44E3-A340-2B12E0931569</gtr:id><gtr:name>Tampere University of Technology</gtr:name><gtr:address><gtr:line1>PO Box 527</gtr:line1><gtr:line4>Tampere</gtr:line4><gtr:postCode>FIN 33101</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Finland</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/926FCE3B-DFAB-4FE7-9BF8-7372B5AA9514"><gtr:id>926FCE3B-DFAB-4FE7-9BF8-7372B5AA9514</gtr:id><gtr:name>German Cancer Research Center</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/EAF8D5E4-4B8A-4F65-B3BF-821C6E1A3D7F"><gtr:id>EAF8D5E4-4B8A-4F65-B3BF-821C6E1A3D7F</gtr:id><gtr:firstName>Effrossyni</gtr:firstName><gtr:surname>Gkrania-Klotsas</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0701652"><gtr:id>527CD8AB-60AE-47C5-894C-23DFDDC43140</gtr:id><gtr:title>Diabetes and Infections</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0701652</gtr:grantReference><gtr:abstractText>Objectives: to determine if diabetes mellitus is an important risk factor for the development of tuberculosis in the United Kingdom
The study will be conducted prospectively and will recruit people diagnosed with tuberculosis and healthy individuals that will serve as controls for comparison. 
It is expected that the study will show that there is a 2 fold increased risk for developing tuberculosis among individuals with diabetes compared to individuals without diabetes and that the risk will be higher independently of ethnicity, frequency of contact with other people with the infection, age or sex.
Anticipated immediate benefits to patients with diabetes include the institution of a screening program attempting to identify tuberculosis infection before it becomes apparent. Traditionally medically underserved minorities are expected to benefit more</gtr:abstractText><gtr:technicalSummary>The Diabetes as a Risk Factor for Tuberculosis will be a Prospective Matched Case-Control Study with two independently matched control groups that will enrol approximately 680 cases of tuberculosis and approximately 1360 controls, in order to investigate the hypothesis that diabetes mellitus significantly increases the risk of developing tuberculosis in the UK.

The study will be ongoing for approximately two and a half years, recruiting patients from areas with a high incidence of tuberculosis, mainly in the areas of East Anglia and East Midlands (Cambridge PCT, Peterborough PCT, Bedford PCT , Luton / Dunstable PCT, Leicester City West PCT). A bibliographic review of the biological pathways mediating the association between diabetes mellitus and tuberculosis, as well as possible biological pathways mediating the above, will be undertaken as well.</gtr:technicalSummary><gtr:fund><gtr:end>2012-04-29</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-12-31</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>376613</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Tampere University of Technology</gtr:collaboratingOrganisation><gtr:country>Finland, Republic of</gtr:country><gtr:description>Enterovirus serology and Diabetes</gtr:description><gtr:id>FBD33D6F-3398-41F1-871D-D5A3A53B89D9</gtr:id><gtr:impact>Multi-disciplinary collaboration, in progress</gtr:impact><gtr:outcomeId>DWRRbfyhhHz-1</gtr:outcomeId><gtr:partnerContribution>Performing measurements in clinical samples that can not be performed in other laboratories. Offering expertise.</gtr:partnerContribution><gtr:piContribution>Project idea, providing samples, analysing data</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>German Cancer Research Center</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Genomic Epidemiology Group</gtr:department><gtr:description>Heidelberg</gtr:description><gtr:id>5A9F4826-BAB0-4889-A6F9-338C95795C99</gtr:id><gtr:impact>Abstracts submitted, manuscripts in preparation</gtr:impact><gtr:outcomeId>58b990b88d3c47.13265000-1</gtr:outcomeId><gtr:partnerContribution>- intellectual contribution to assay development
- measurements</gtr:partnerContribution><gtr:piContribution>Ongoing extension project on genetic architecture to immune response to viral infections</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Epidemiology Unit</gtr:department><gtr:description>GWAS</gtr:description><gtr:id>A1273326-1BB7-4A9E-BEA6-665DBBB896BB</gtr:id><gtr:impact>Two manuscripts in progress</gtr:impact><gtr:outcomeId>eYkmcLsqJMX-1</gtr:outcomeId><gtr:partnerContribution>Technical support by collaborators for GWAS</gtr:partnerContribution><gtr:piContribution>I have submitted data to a GWAS study which is ongoing</gtr:piContribution><gtr:sector>Multiple</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School visit - King's College School</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>160D895C-164A-4B63-9E4A-651041541156</gtr:id><gtr:impact>Two Year 1 classes (40 children) attended the activity for 2 hours. See summary in
http://www.infectiousdisease.cam.ac.uk/news/let2019s-talk-about-science-how-public-engagement-can-work-for-you


School asked for the activity to be repeated yearly</gtr:impact><gtr:outcomeId>A3bF1u51GhU</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Cambridge Biomedical Research Centre</gtr:department><gtr:description>BRC</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>0FE76317-6AFE-496E-AEBF-795A9C6BF302</gtr:id><gtr:outcomeId>58b99202ce7192.30120709</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2017-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Lecture and Workshop on Research ethics</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>8B8A403B-FA34-4D9F-AAD2-08193BECDE46</gtr:id><gtr:outcomeId>Jz8hdp9xGxf</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>0E2B30CD-CFEA-40DF-B71B-192D9719BC79</gtr:id><gtr:title>Report from the second cytomegalovirus and immunosenescence workshop.</gtr:title><gtr:parentPublicationTitle>Immunity &amp; ageing : I &amp; A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7bee66e5d800437620ae80666b3b0c95"><gtr:id>7bee66e5d800437620ae80666b3b0c95</gtr:id><gtr:otherNames>Wills M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1742-4933</gtr:issn><gtr:outcomeId>pm_16507_27_22035114</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2AEE682F-9028-485C-AF31-EC5018B7AC71</gtr:id><gtr:title>Differential white blood cell count and type 2 diabetes: systematic review and meta-analysis of cross-sectional and prospective studies.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a645ff5c1932a40dec603af594d127b2"><gtr:id>a645ff5c1932a40dec603af594d127b2</gtr:id><gtr:otherNames>Gkrania-Klotsas E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>fMoMiiCtZh2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0FD6F39-E1C9-4457-A997-0380F04C70EF</gtr:id><gtr:title>Infections and metabolic diseases</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e2728a5445eb08094bc325262b32b44a"><gtr:id>e2728a5445eb08094bc325262b32b44a</gtr:id><gtr:otherNames>Gkrania-Klotsas Effrossyni</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>58b994073aee83.50101285</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>856C4032-2277-42E2-817E-BE4571FED355</gtr:id><gtr:title>Higher immunoglobulin G antibody levels against cytomegalovirus are associated with incident ischemic heart disease in the population-based EPIC-Norfolk cohort.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a645ff5c1932a40dec603af594d127b2"><gtr:id>a645ff5c1932a40dec603af594d127b2</gtr:id><gtr:otherNames>Gkrania-Klotsas E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>pm_16507_27_23045624</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3958A1E8-0437-4E92-831E-2BFC45920FAF</gtr:id><gtr:title>The association between prior infection with five serotypes of Coxsackievirus B and incident type 2 diabetes mellitus in the EPIC-Norfolk study.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a645ff5c1932a40dec603af594d127b2"><gtr:id>a645ff5c1932a40dec603af594d127b2</gtr:id><gtr:otherNames>Gkrania-Klotsas E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>pm_16507_27_22231126</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0701652</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>9A8BEDCC-D902-4C9A-8CCF-C974265EA3FB</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.4  Surveillance and distribution</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>